Dr. Michael Tirant - Information for the Hungarian patients

September 29, 2010, Budapest – Australian medical researcher and specialist practitioner, Dr. Michael Tirant today issued the following public interest communiqué, and kindly requests representatives of the medical and pharmaceutical media, as well as professional organizations, and patients’ interest organizations to distribute its message, which is of high interest to 300 000 patients suffering from psoriasis in Hungary.

Dr. Michael Tirant, Australian medical researcher and specialist practitioner hereby officially informs psoriasis sufferers and all parties to whom it may concern, that products manufactured in Austria and distributed in Hungary under the „Dr. Michaels” brand name by Rica Hungária Ltd. are not the same as the original, Australian products of Dr. Michael Tirant.

Dr. Michael Tirant also stresses that he only assumes responsibility for the healing effects of the original products made in Australia, which are manufactured in accordance with the recipe and technology he developed, and tested in clinical trials.

“The original products for psoriasis and eczema that we manufacture in Australia are currently not available in Hungary”, said Dr. Michael Tirant.
“The original products, which are produced along a unique recipe and manufacturing technology, and have been tested in clinical trials will be reintroduced to the Hungarian market in January 2011, under the PSORATINEX® brand name, he added.

Dr. Michael Tirant’s decision to change the brand name is aimed at clearly distinguishing his products from the ones manufactured in Austria and currently distributed in Hungary under „Dr. Michaels” label.

Until Psoratinex is introduced to the Hungarian market, patients may purchase the original Australian products of Dr. Michael Tirant at Slovakian pharmacies listed at the end of this press release (they speak Hungarian). The listed pharmacies are prepared to satisfy the demand of Hungarian customers, however, if one is planning to purchase large quantities of the products, it is advised to call the pharmacies, in advance.

Dr. Michael Tirant hereby advises patients that in the Czech Republic and in Slovakia the original products continue to be sold under the „Dr. Michaels” label.

Slovakian pharmacies selling the original Australian products near the Hungarian-Slovakian border:

Párkány – Sturovo (45 km from Budapest)
LEKÁREŇ MAJA
Hlavná 49, 94301 Štúrovo
Tel: +421 36-752-2506
Map

Komárom – Komarno (60 km from Budapest, 30 km from Győr, all the way on motorway)
LEKÁREŇ PRI VÁHU (Vág patika)
Cím: Jazerná 15. (Tó utca), Komárno 945 01, Szlovákia
Tel. +421-35-770-2910
E-mail: inet.lpv@nextra.sk
Map

How can you tell if the product is an original product of Dr. Michael Tirant?
Always check the label on the packaging:

Manufacturer: Psoriasis and Skin Clinic, Australia
Distributor: FRANKL Pharma s.r.o.

For more information, please contact:

Hill & Knowlton Hungary Kft.
Tóth Beáta
E-mail: beata.toth@hillandknowlton.com
Tel.: +36 1 351-9101

You may send inquiries or complaints addressed to Dr. Michael Tirant in Hungarian to Hill & Knowlton Hungary, the representative of Dr. Michael Tirant, to the following e-mail address: psoriasis@hillandknowlton.com

Dr Michael Tirant was born in the Seychelles in 1955. Dr Tirant is a Medical Researcher, a Clinical Biochemist and Scientist, and is a Practitioner specializing in the treatment of Psoriasis and other skin conditions. He completed much of his formal studies at Monash University, Victoria, Australia and after completing his undergraduate studies, Dr Tirant's intense interest in research finalized in attaining his Doctorate in 1986.

The ‘Dr. Michael’s’ product group was developed by Dr. Michael Tirant, focusing on the use of natural components in creating effective treatment for skin problems caused by psoriasis and eczema.

Clinical trials of the product group were completed over the past 10 years and in a number of countries, managed by internationally acknowledged professors at the most prominent European skin clinics, including Prof. Jana Hercogová and Prof. František Novotny in the Czech Republic.

The success rate of clinical trials is over 80% for patients with psoriasis, which is a ground-breaking achievement both in treating the symptoms of psoriasis and in improving patients’ quality of life.

The prevalence of psoriasis in the Hungarian population is estimated to be around 5%.